WT
VXRT

Wellcome Trust’s Vaxart VXRT Stock Holding History

Wellcome Trust’s Portfolio VXRT Stock Details VXRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-11,579
Closed -$72K – 22
2017
Q4 		$72K Hold
11,579
– – ﹤0.01% 21
2017
Q3 		$87K Buy
+11,579
New +$78.8K ﹤0.01% 21
2014
Q3 		– Sell
-4,389
Closed -$137K – 32
2014
Q2 		$137K Buy
+4,389
New +$183K ﹤0.01% 30

Other funds holding VXRT

KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Carlson Capital Management Northfield, Minnesota $2.29B AUM 7.48% 1-Year Est. Return
GCIA
Gabelli & Co Investment Advisers Rye, New York $674M AUM 64.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
RFWA
RPg Family Wealth Advisory Burlington, Massachusetts $479M AUM 25.83% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

Wellcome Trust's VXRT Position: Q1 2018 in Review

Wellcome Trust sold out of Vaxart (VXRT) in Q1 2018, closing a stake of 11,579 shares — an estimated $72K sold.

Wellcome Trust first reported a position in VXRT in Q2 2014 and held it in 3 quarters. The position peaked at $137K in Q2 2014. 18 funds tracked by Wall St. Rank hold VXRT as of Q1 2018.

  • Wellcome Trust reported no remaining Vaxart position as of Q1 2018 after selling out during the quarter.
  • Wellcome Trust sold 11,579 Vaxart shares in Q1 2018, an estimated $72K.
  • Wellcome Trust first reported a position in Vaxart in Q2 2014 and held it in 3 quarters.
  • Wellcome Trust's Vaxart position peaked at $137K in Q2 2014.
  • 18 funds tracked by Wall St. Rank held Vaxart as of Q1 2018.

Based on Wellcome Trust's 13F filing for Q1 2018, filed 18 Apr 2018.